Lv42
430 积分 2024-06-07 加入
Immune-Related Adverse Events of Immune Checkpoint Inhibitors
4小时前
已完结
Clinical and translational attributes of immune-related adverse events
8小时前
已完结
Biomarkers for immunotherapy of hepatocellular carcinoma
9小时前
已完结
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
10小时前
已完结
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
10小时前
已完结
Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management
1天前
已完结
GOLD COPD report: 2024 update
14天前
已完结
Vitamin D and lung disease
1个月前
已完结
Vitamin D Deficiency
1个月前
已完结
Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
1个月前
已完结
皖公网安备34019202002308
